Sylvatic dengue viruses share the pathogenic potential of urban/endemic dengue viruses

Journal of Virology

Volumn 84, Issue 7, 2010, Pages 3726-3727

  Vasilakis, Nikos ^a   Cardosa, Jane ^b   Diallo, Mawlouth ^c   Sall, Amadou A ^c   Holmes, Edward C ^d   Hanley, Kathryn A ^e   Weaver, Scott C ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITI MALAYSIA SARAWAK   (Malaysia)

^c INSTITUT PASTEUR DE DAKAR   (Senegal)

^d PENNSYLVANIA STATE UNIVERSITY   (United States)

^e NEW MEXICO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CELL CULTURE; DENGUE; DENGUE VIRUS; DISEASE SEVERITY; EX VIVO STUDY; GENOTYPE; HUMAN; LETTER; NONHUMAN; PRIORITY JOURNAL; SEROTYPE; VIREMIA; VIRUS STRAIN;

ANIMALS; DENGUE; DENGUE VIRUS; HUMANS; MICE;

DENGUE VIRUS GROUP;

EID: 77949396900     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02640-09     Document Type: Letter

References (19)

1. Binh, P. T., S. Matheus, V. T. Huong, X. Deparis, and V. Marechal. 2009. Early clinical and biological features of severe clinical manifestations of dengue in Vietnamese adults. J. Clin. Virol. 45:276-280.
2. Blaney, J. E., Jr., A. P. Durbin, B. R. Murphy, and S. S. Whitehead. 2006. Development of a live attenuated dengue virus vaccine using reverse genetics. Viral Immunol. 19:10-32.
3. Cardosa, J., M. H. Ooi, P. H. Tio, D. Perera, E. C. Holmes, K. Bibi, and Z. Abdul Manap. 2009. Dengue virus serotype 2 from a sylvatic lineage isolated from a patient with dengue hemorrhagic Fever. PLoS Negl. Trop. Dis. 3:e423.
4. Carey, D. E., O. R. Causey, S. Reddy, and A. R. Cooke. 1971. Dengue viruses from febrile patients in Nigeria, 1964-68. Lancet i:105-106.
5. Cornet, M. 1993. Dengue virus in Africa, p. 39-47. In P. Thongcharoen (ed.), Monograph on dengue/dengue haemorrhagic fever. WHO regional publication, South-East Asia. World Health Organization, Regional Office for South-East Asia, New Delhi, India.
6. Diallo, M., Y. Ba, A. A. Sall, O. M. Diop, J. A. Ndione, M. Mondo, L. Girault, and C. Mathiot. 2003. Amplification of the sylvatic cycle of dengue virus type 2, Senegal, 1999-2000: entomologic findings and epidemiologic considerations. Emerg. Infect. Dis. 9:362-367.
7. Fagbami, A. H., T. P. Monath, and A. Fabiyi. 1977. Dengue virus infections in Nigeria: a survey for antibodies in monkeys and humans. Trans. R. Soc. Trop. Med. Hyg. 71:60-65.
8. Libraty, D. H., T. P. Endy, H. S. Houng, S. Green, S. Kalayanarooj, S. Suntayakorn, W. Chansiriwongs, D. W. Vaughn, A. Nisalak, F. A. Ennis, and A. L. Rothman. 2002. Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. J. Infect. Dis. 185:1213-1221.
9. Monlun, E., H. Zeller, M. Traore-Lamizana, J. P. Hervy, F. Adam, M. Mondo, and J. P. Digoutte. 1992. Caracteres cliniques et epidemiologiques de la dengue 2 au Senegal. Med. Mal. Infect. 22:718-721.
10. Mota, J., and R. Rico-Hesse. 2009. Humanized mice show clinical signs of dengue fever according to infecting virus genotype. J. Virol. 83:8638-8645.
11. Murgue, B., C. Roche, E. Chungue, and X. Deparis. 2000. Prospective study of the duration and magnitude of viraemia in children hospitalised during the 1996-1997 dengue-2 outbreak in French Polynesia. J. Med. Virol. 60: 432-438.
12. Robin, Y., M. Cornet, G. Heme, and G. Le Gonidec. 1980. Isolement du virus dela dengue au Senegal. Ann. Virol. (Inst. Pasteur) 131:149-154.
13. Saluzzo, J. F., M. Cornet, C. Adam, M. Eyraud, and J. P. Digoutte. 1986. Dengue 2 in eastern Senegal: serologic survey in simian and human populations. 1974-85. Bull. Soc Pathol. Exot. Filiales 79:313-322. (In French.)
14. Saluzzo, J. F., M. Cornet, P. Castagnet, C. Rey, and J. P. Digoutte. 1986. Isolation of dengue 2 and dengue 4 viruses from patients in Senegal. Trans. R. Soc. Trop. Med. Hyg. 80:5.
15. Vasilakis, N., K. A. Hanley, and S. C. Weaver. 2010. Dengue virus emergence from its sylvatic cycle, p. 183-220. In K. A. Hanley and S. C. Weaver (ed.), Frontiers in dengue virus research. Caister Academic Press, Norfork, United Kingdom.
16. Vasilakis, N., E. J. Shell, E. B. Fokam, P. W. Mason, K. A. Hanley, D. M. Estes, and S. C. Weaver. 2007. Potential of ancestral sylvatic dengue-2 viruses to re-emerge. Virology 358:402-412.
17. Vasilakis, N., R. B. Tesh, and S. C. Weaver. 2008. Sylvatic dengue virus type 2 activity in humans, Nigeria, 1966. Emerg. Infect. Dis. 14:502-504.
18. Vaughn, D. W., S. Green, S. Kalayanarooj, B. L. Innis, S. Nimmannitya, S. Suntayakorn, T. P. Endy, B. Raengsakulrach, A. L. Rothman, F. A. Ennis, and A. Nisalak. 2000. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J. Infect. Dis. 181:2-9.
19. Wills, B., V. N. Tran, T. H. Nguyen, T. T. Truong, T. N. Tran, M. D. Nguyen, V. D. Tran, V. V. Nguyen, T. T. Dinh, and J. Farrar. 2009. Hemostatic changes in Vietnamese children with mild dengue correlate with the severity of vascular leakage rather than bleeding. Am. J. Trop. Med. Hyg. 81:638-644.